Published in Dis Colon Rectum on January 11, 1972
Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery (1988) 3.47
The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg (1984) 3.08
Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg (1989) 2.79
The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg (1979) 1.93
Repeat hepatic resections for metastatic colorectal cancer. Ann Surg (1994) 1.05
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol (1987) 1.42
Squamous-cell carcinoma of the pilonidal sinus: report of a case and review of the literature. J Surg Oncol (1979) 1.08
Malignant mesothelioma. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer (1983) 1.07
Phase II study of tamoxifen: report of 74 patients with stage IV breast cancer. Cancer Treat Rep (1976) 1.02
A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer. Cancer (1985) 0.96
Carcinoma of the anal gland: case report and review of the literature. J Surg Oncol (1983) 0.95
Intraoperative cholangiography. A review of indications and analysis of age-sex groups. Ann Surg (1983) 0.93
A prospective study of wound infections. Am Surg (1969) 0.88
Acute myelogenous leukemia in patients receiving chlorambucil as long-term adjuvant chemotherapy for stage II breast cancer. Cancer Treat Rep (1978) 0.83
Eastern Cooperative Oncology Group: a comparison of adjuvant doxorubicin and observation for patients with localized soft tissue sarcoma. J Clin Oncol (1987) 0.82
Range of action of heparin in suppressing canine gastric acid secretion. Surg Gynecol Obstet (1966) 0.80
Endotoxin inhibition of luteinizing hormone in sheep. Domest Anim Endocrinol (2003) 0.79
Giant cell carcinoma of the lung. Review of literature and report of five cases. Arch Surg (1967) 0.78
Hydroxyurea (NSC-32065) in biologic fluids: dose-concentration relationship. Cancer Chemother Rep (1965) 0.77
Dimethyl sulfoxide conference. Science (1966) 0.77
Clinical trial of hydrazine sulfate in solid tumors. Cancer Treat Rep (1976) 0.76
Methotrexate alone or with regional subcutaneous Corynebacterium parvum in the treatment of recurrent and metastatic squamous cancer of the head and neck. Cancer (1982) 0.76
Breast carcinoma in a 46, XX true hermaphrodite. Cancer (1982) 0.76
Phase II study of hydroxyurea administered intermittently in malignant melanoma. Am Surg (1970) 0.75
Mishandling misconduct: the NSABP lumpectomy trial. National Surgical Adjuvant Breast and Bowel Project. JAMA (1994) 0.75
Concomitant hydroxyurea and radiotherapy in the preoperative management of locally advanced lung cancer. Am Surg (1970) 0.75
Breast cancer: are imaging studies cost effective following breast cancer and adjuvant therapy? Semin Oncol (1995) 0.75
Malignant fibrous histiocytoma: report of five cases and a review of the literature. J Surg Oncol (1978) 0.75
Phase I-II trial of intramuscularly administered bleomycin. Eur J Cancer (1977) 0.75
Colorectal cancer--prognostic signs in "local disease". J Surg Oncol (1975) 0.75
Hydroxyurea in bladder carcinoma. Invest Urol (1966) 0.75
Estrogen receptor protein and its correlation to recurrent breast cancer. A study of 213 patients at the Pennsylvania Hospital. Cancer Clin Trials (1981) 0.75
Effects of intravesical instillation of DMSO on the urinary bladder of the dog: preliminary report. Ann N Y Acad Sci (1967) 0.75
Methacycline treatment of infections related to surgery. Am Surg (1968) 0.75
Concomitant hydroxyurea and irradiation. Clinical experience with 100 patients with advanced head and neck cancer at Pennsylvania hospital. Am J Surg (1977) 0.75
Steps in the development of the profession of podiatry, as noted in its professional journal. J Am Podiatry Assoc (1974) 0.75
Evaluation of bleomycin, chlorozotocin, MGBG, and bruceantin in patients with advanced soft tissue sarcoma, bone sarcoma, or mesothelioma. Invest New Drugs (1985) 0.75
Six year survival in the combined treatment of far advanced head and neck cancer under a combined therapy program. Am J Surg (1973) 0.75
Treatment of astrocytoma with hydroxyurea and irradiation: report of six patients with 18-month follow-up. Am Surg (1970) 0.75
A phase II study of m-AMSA in patients with malignant mesothelioma. Cancer Chemother Pharmacol (1983) 0.75
Results of a phase II protocol for evaluation of new chemotherapeutic regimens in patients with inoperable non-small cell lung carcinoma (EST-2575, generation I). Cancer Treat Rep (1981) 0.75
Concomitant hydroxyurea and radiotherapy in the management of 60 patients with head and neck cancer. Am Surg (1969) 0.75
Fear of success and locus of control in young women. J Consult Clin Psychol (1974) 0.75
Hydroxyurea in the management of head and neck cancer. II. Surgical aspects. Plast Reconstr Surg (1967) 0.75
Hydroxyurea in stage D carcinoma of prostate. Urology (1977) 0.75
Identification of an S-antigen-like molecule in human choroid plexus and cerebrospinal fluid. Eye (Lond) (1992) 0.75
Heparin inhibition of gastric secretion in duodenal ulcer and control patients. Surg Gynecol Obstet (1966) 0.75
Gastric carcinoma survival at the Pennsylvania Hospital -- 1964 to 1974. J Surg Oncol (1978) 0.75
Section on Cancer Chemotherapy, Department of Surgery, Pennsylvania Hospital, Philadelphia. Am Fam Physician (1981) 0.75
The effect of retinal autoantigens and their peptides on the inhibition of experimental autoimmune uveitis. Eye (Lond) (1992) 0.75
Hydroxyurea (NSC-32065) intermittent therapy in malignant diseases. Cancer Chemother Rep (1969) 0.75
Spontaneous rupture of the esophagus. Am Surg (1969) 0.75
Combined chemotherapy and radiotherapy. Preliminary results of clinical trial of hydroxyurea and x-irradiation in the treatment of epidermoid cancers of the head and neck. Am Surg (1967) 0.75